Trials / NCT07082855
A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa
Not yet recruiting Phase 3 Drug / neuroprotection
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Treatment
- Minocycline 100mg; Minocycline 200mg; Placebo
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa, Inherited Retinal Dystrophy, Retina Disorder
- Ages
- 18 Years to 60 Years
- Enrollment
- 126 participants
- Started
- 2025-07-15
- Main results expected
- 2028-02-28
- Results posted
- Not yet
- Record last updated
- 2025-07-24
What the study is testing
This is a multicenter, double-blind, randomized controlled clinical trial to get high - level evidence on minocycline's efficacy and safety（100mg/d, 200mg/d) for Retinitis pigmentosa and to find the optimal treatment dose.
Where it runs
China (1)
- Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong